| 摘要 |
<p>The present invention is a method of inhibiting, or blocking, the binding of human neutrophils to activated endothelial cells, or T-cell mediated chemotaxis in a patient in need thereof, which method comprises administering to said patient an effective amount of a compound which binds the CXCR2 receptor.</p> |
